Abstract:Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease distributed globally in all ethnicities with increasing prevalence. If left untreated, the disease will lead to cirrhosis, liver failure, or death. The intestinal microbiota is a complex ecosystem located in the human intestine, which extensively affects the human physiological and pathological processes. With more and more in-depth understandings of intestinal microbiota, a substantial body of studies have verified that the intestinal microbiota plays a crucial role in a variety of digestive system diseases, including alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). However, only a few studies have paid attention to evaluate the relationship between AIH and the intestinal microbiota. While AIH pathogenesis is not fully elucidated yet, some studies have indicated that intestinal microbiota putatively made significant contributions to the occurrence and the development of AIH by triggering several specific signaling pathways, altering the metabolism of intestinal microbiota, as well as modulating the immune response in the intestine and liver. By collecting the latest related literatures, this review summarized the increasing trend of the aerobic bacteria abundance in both AIH patients and AIH mice models. Moreover, the combination of specific bacteria species was found distinct to AIH patients, which could be a promising tool for diagnosing AIH. In addition, there were alterations of luminal metabolites and immune responses, including decreased short-chain fatty acids (SCFAs), increased pathogen associated molecular patterns (PAMPs), imbalanced regulatory T (Treg)/Th17 cells, follicular regulatory T (TFR)/follicular helper T (TFH) cells, and activated natural killer T (NKT) cells. These alterations participate in the onset and the progression of AIH via multiple mechanisms. Therefore, some therapeutic methods based on restoration of intestinal microbiota composition, including probiotics and fecal microbiota transplantation (FMT), as well as targeted intestinal microbiota-associated signaling pathways, confer novel insights into the treatment for AIH patients.

Integrated Bioinformatic Analysis Revealed Biological Processes and Immune Cells Implicated in Autoimmune Hepatitis

IL-17 Imbalance Promotes the Pyroptosis in Immune-Mediated Liver Injury Through STAT3-IFI16 Axis.

Exploration the Significance of Tfh and Related Molecules on C57BL/6 Mice Model of Experimental Autoimmune Hepatitis

The Imbalance Between Foxp3(+)Tregs and Th1/Th17/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis

Characteristics of peripheral blood mononuclear cells and potential related molecular mechanisms in patients with autoimmune hepatitis: a single-cell RNA sequencing analysis

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis

The Gut Microbiota: A Novel Player in Autoimmune Hepatitis

Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease

Deficiency of canonical Wnt/β-catenin signaling in hepatic dendritic cells triggers autoimmune hepatitis.

Comprehensive analysis of immune signatures in primary biliary cholangitis and autoimmune hepatitis

Spontaneous Development of an Autoimmune Hepatitis – Primary Biliary Cholangitis Overlap Syndrome in Dntgfβrii Aire−/− Mice

Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies

Zvad Alleviates Experimental Autoimmune Hepatitis in Mice by Increasing the Sensitivity of Macrophage to TNFR1-dependent Necroptosis.

Genome‐wide Meta‐analysis Identifies Novel Susceptibility Loci for Autoimmune Hepatitis Type 1

The role of amino acid metabolism in autoimmune hepatitis

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver

Human Menstrual Blood-Derived Stem Cells Alleviate Autoimmune Hepatitis Via JNK/MAPK Signaling Pathway in Vivo and in Vitro

1,25(OH) 2 D 3 -Treated Mouse Bone Marrow-Derived Dendritic Cells Alleviate Autoimmune Hepatitis in Mice by Improving TFR/TFH Imbalance

The Clinical Significance of Hepatic CD69 + CD103 + CD8 + Resident‐Memory T Cells in Autoimmune Hepatitis